-
76. “USE OF ASCORBATE-RICH DIALYSATE IN HEMODIALYSIS PATIENTS”
I. Griveas
417 Army Share Fund Hospital of Athens, Greece
Nephrology Dialysis and Transplantation , June 2020, Volume 35, Number 53
-
77. Heat-Shock Protein 27 kinetics in end stage renal disease patientsI Griveas* Nephrology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece Archives of Clinical Nephrology, September 2020
I Griveas*
Nephrology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece
Archives of Clinical Nephrology, September 2020
-
78. Vascular Endothelial Growth Factor and Diabetic Nephropathy
Ioannis Griveas*
Nephrology Department in 417 Army Share Fund Hospital, Athens, Greece
Biomedical Journal of Scientific and Technical Research, February 2020
-
79. COVID-19 infection in patients receiving hemodialysis in Athens: Findings, experience, and outcome from a single Dialysis Unit
Ioannis Griveas1 *, Antonios Schoinas1 , Anthi Balitsari1 , Gerasimos Asimakopoulos1 , Evaggelos Pratilas1 1
Dept. of Nephrology, Army Share Fund Hospital of Athens 417 NIMTS, Greece
Medical Science and Discovery, March 2021
-
80. SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AND COVID-19 INFECTION IN HEMODIALYSIS PATIENTS
I.Griveas
417 Army Share Fund Hospital of Athens, Greece
Nephrology Dialysis and Transplantation , May 2021, Volume 36, Supplement 1
